Philip Kuehl
Director of Science and Technology Aptar Group Inc
Seminars
Wednesday 20th May 2026
Utilization of Formulation and Devices for Intranasal Delivery
10:00 am
- Highlight general formulation and delivery learnings from model peptide/biologic compounds and how they pair with Aptar devices and proof of concept in vivo data
- Discuss formulation and device strategies to enable delivery of mucosal vaccines
- Emphasize using formulation, device, and in vivo studies to address problem statements in intranasal drug delivery with the following
